Hi there,

If you think Democracy Now!’s reporting is a critical line of defense against war, climate catastrophe and authoritarianism, please make your donation of $10 or more right now. Today, a generous donor will DOUBLE your donation, which means it’ll go 2x as far to support our independent journalism. Democracy Now! is funded by you, and that’s why we’re counting on your donation to keep us going strong. Please give today. Every dollar makes a difference—in fact, gets doubled! Thank you so much.
-Amy Goodman

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.


Supreme Court Appears Poised to Preserve Access to Abortion Pill Mifepristone

HeadlineMar 27, 2024

The U.S. Supreme Court appears set to preserve access to the abortion pill mifepristone, which is used for roughly two-thirds of all abortions in the United States. Oral arguments were held Tuesday in a case brought by a group of anti-choice medical associations which have sought to overturn moves by the FDA to increase accessibility to the drug, which was first approved over 20 years ago. On Tuesday, several justices questioned if the doctors even had standing to bring the challenge. Abortion rights activists rallied outside the Supreme Court ahead of the ruling.

Laurie Woodward Garcia: “This decision should not be held by a couple of justices. It’s a decision between a doctor and a family, and that’s how it’s always been. And let’s be clear: It’s safe and accessible, and has been for over 20 years, with hundreds of thousands of people using this medicine.”

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation